KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Current Assets (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Current Assets for 11 consecutive years, with $520.8 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Current Assets changed N/A year-over-year to $520.8 million, compared with a TTM value of $520.8 million through Jun 2025, changed N/A, and an annual FY2024 reading of $1.0 billion, up 73.32% over the prior year.
  • Current Assets was $520.8 million for Q2 2025 at Medpace Holdings, down from $821.4 million in the prior quarter.
  • Across five years, Current Assets topped out at $1.0 billion in Q3 2024 and bottomed at $328.9 million in Q2 2022.
  • Average Current Assets over 5 years is $560.3 million, with a median of $527.1 million recorded in 2021.
  • The sharpest move saw Current Assets plummeted 51.66% in 2022, then soared 130.04% in 2024.
  • Year by year, Current Assets stood at $690.9 million in 2021, then tumbled by 51.66% to $334.0 million in 2022, then soared by 77.81% to $593.8 million in 2023, then surged by 73.32% to $1.0 billion in 2024, then crashed by 49.4% to $520.8 million in 2025.
  • Business Quant data shows Current Assets for MEDP at $520.8 million in Q2 2025, $821.4 million in Q1 2025, and $1.0 billion in Q4 2024.